SS-31: Best Telehealth Providers for Longevity & Anti-Aging (2026)
A mitochondria-targeting tetrapeptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin from oxidative damage. Restores mitochondrial function in aged and metabolically stressed cells, with clinical trials in heart failure and Barth syndrome.
Reviewed by Dr. James Okafor, PharmDPharmDSS-31 at a Glance
Category
Longevity & Anti-Aging
Administration
Subcutaneous injection
Telehealth Providers
2 compared
Price Range
$280 – $350/mo
Typical Dose
5-40mg
Frequency
Once daily or several times weekly
Protocol Duration
8-12 weeks
Prescription
Required
Research highlight: SS-31 selectively concentrates in the inner mitochondrial membrane at 5000x cytoplasmic levels, binding cardiolipin to protect electron transport chain architecture and restore oxidative phosphorylation efficiency in aging tissues.
What is SS-31 Used For?
Also known as: Elamipretide, Bendavia, MTP-131
- Mitochondrial function
- Cellular energy
- Heart health
- Age-related tissue decline
How SS-31 Works
SS-31 (Elamipretide) is a mitochondria-targeting tetrapeptide that selectively concentrates in the inner mitochondrial membrane — achieving concentrations 5000x higher than in the cytoplasm. It binds to cardiolipin, a phospholipid critical to the structural integrity of the mitochondrial electron transport chain complexes. As cardiolipin is oxidized during aging and metabolic stress, electron transport chain efficiency drops and reactive oxygen species (ROS) production rises. SS-31 protects cardiolipin from peroxidation, restoring cristae architecture and oxidative phosphorylation efficiency.
SS-31Dosing & Administration
| Typical Dose | 5-40mg |
| Frequency | Once daily or several times weekly |
| Protocol Duration | 8-12 weeks |
| Route | Subcutaneous injection |
Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.
What to Expect from SS-31
In Phase 2 trials for Barth syndrome (a cardiolipin deficiency disease) and heart failure, SS-31 shows measurable improvements in exercise capacity and cardiac function within 8–12 weeks. Off-label use for age-related fatigue and metabolic decline focuses on subjective energy improvement over 6–12 weeks. Anti-aging effects at the cellular level require sustained use and are tracked through biomarkers rather than felt acutely.
Who Should Consider SS-31?
- Mitochondrial dysfunction and primary mitochondrial diseases
- Age-related fatigue and energy decline
- Heart failure with preserved ejection fraction (HFpEF)
- Barth syndrome and cardiolipin deficiency conditions
SS-31 Side Effects
- Injection site reactions (mild, common)
- Headache (uncommon)
- Nausea (rare)
- Generally well-tolerated across all published trials
This is not a complete list of side effects. Always consult your prescribing physician before starting SS-31.
2 Telehealth Providers Offering SS-31
Sorted by lowest price. All providers require a prescription from a licensed physician.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Defy Medical Tampa, FL | $280/monthly | Standard protocol | 4.1/5 | Video Telehealth | Included |
| TruLife Health Scottsdale, AZ | $350/monthly | Standard protocol | 4.1/5 | Video Telehealth | Included |
How to Choose the Best Telehealth Provider for Longevity Peptides
Anti-aging peptide protocols are long-term investments. The right provider combines deep scientific understanding with responsible monitoring.
Biomarker-Driven Approach
Longevity medicine works best when guided by measurable biomarkers — telomere length, NAD+ levels, inflammatory markers, mitochondrial function panels. Providers who track these can adjust protocols based on objective data, not just subjective reports.
Multi-Pathway Protocol Design
Aging involves multiple hallmarks (telomere attrition, mitochondrial dysfunction, senescent cell accumulation, NAD+ decline). The best providers design protocols that address multiple hallmarks simultaneously using complementary peptides.
Physician Expertise in Longevity Medicine
Anti-aging peptides like Epithalon, FOXO4-DRI, and SS-31 operate at the frontier of research. Look for physicians with fellowship training or deep published expertise in regenerative or longevity medicine.
Safety Monitoring for Experimental Peptides
Some longevity peptides (FOXO4-DRI, SS-31) have limited long-term human safety data. Responsible providers clearly communicate experimental status, obtain informed consent, and monitor regularly for adverse effects.
Sustainable Long-Term Protocols
Anti-aging is not a one-month protocol. Look for providers offering structured long-term programs with quarterly lab reviews, dose adjustments, and clear communication about expected timelines.
Compounding Pharmacy Quality
Longevity peptides often require precise formulation and cold-chain shipping. Verify your provider works with reputable compounding pharmacies that follow USP 797/800 standards for sterile compounding.
Frequently Asked Questions About SS-31
Is SS-31 in clinical trials?
Yes — Elamipretide (SS-31) has completed Phase 2 trials for Barth syndrome, heart failure with preserved ejection fraction (HFpEF), and primary mitochondrial myopathy, conducted by Stealth BioTherapeutics. Results show functional improvements without major safety signals. Phase 3 Barth syndrome trials have been conducted. Off-label use through compounding pharmacies is active.
How does SS-31 differ from CoQ10 for mitochondrial support?
CoQ10 is an electron carrier within the electron transport chain that can supplement declining CoQ10 levels. SS-31 works at a more upstream level — protecting the structural scaffold (cardiolipin) that organizes the ETC complexes. SS-31 can restore mitochondrial function even when CoQ10 levels are normal, addressing the architecture of the ETC rather than just cofactor availability.
Who is SS-31 most appropriate for?
SS-31 is most studied and most appropriate for patients with documented mitochondrial dysfunction: primary mitochondrial diseases (Barth syndrome, MELAS), age-related heart failure with preserved ejection fraction (HFpEF), and severe fatigue syndromes. It is also used by longevity practitioners for age-related mitochondrial decline in metabolically active tissues.
Can SS-31 be combined with other anti-aging peptides?
Yes. SS-31 is complementary to NAD+ (which replenishes the electron carrier cofactor) and MOTS-c (which activates AMPK-mediated mitochondrial biogenesis). Together these three peptides address mitochondrial aging from structural (SS-31), cofactor (NAD+), and signaling (MOTS-c) angles.
SS-31 Alternatives for Longevity & Anti-Aging
Compare other longevity & anti-aging peptides available through telehealth.
Epithalon
A synthetic tetrapeptide studied for its ability to activate telomerase, the enzyme responsible for maintaining telomere length. Research suggests potential anti-aging effects at the cellular level.
FOXO4-DRI
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
MOTS-c
A mitochondria-derived peptide encoded within the mitochondrial genome. MOTS-c regulates metabolic homeostasis, enhances insulin sensitivity, and has shown promise in extending healthspan in animal studies. Levels naturally decline with age.
NAD+
A coenzyme found in every living cell, critical for energy metabolism and cellular repair. Levels decline with age, and supplementation is used to support longevity and cognitive function.
Thymosin Alpha-1
A naturally occurring peptide first isolated from the thymus gland. FDA-orphan-drug designated, it enhances immune function by stimulating T-cell maturation and modulating cytokine production.